Curi RMB Capital’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-249,885
| Closed | -$4.44M | – | 1033 |
|
|
2018
Q3 | $4.44M | Sell |
249,885
-15,000
| -6% | -$258K | 0.11% | 225 |
|
|
2018
Q2 | $3.65M | Hold |
264,885
| – | – | 0.09% | 253 |
|
|
2018
Q1 | $2.41M | Hold |
264,885
| – | – | 0.06% | 353 |
|
|
2017
Q4 | $1.13M | Hold |
264,885
| – | – | 0.03% | 465 |
|
|
2017
Q3 | $373K | Hold |
264,885
| – | – | 0.01% | 566 |
|
|
2017
Q2 | $397K | Hold |
264,885
| – | – | 0.01% | 564 |
|
|
2017
Q1 | $681K | Buy |
264,885
+21,500
| +9% | +$49.7K | 0.03% | 337 |
|
|
2016
Q4 | $621K | Buy |
243,385
+25,500
| +12% | +$73.2K | 0.03% | 285 |
|
|
2016
Q3 | $673K | Hold |
217,885
| – | – | 0.04% | 282 |
|
|
2016
Q2 | $699K | Hold |
217,885
| – | – | 0.04% | 271 |
|
|
2016
Q1 | $675K | Buy |
217,885
+400
| +0.2% | +$1.31K | 0.04% | 249 |
|
|
2015
Q4 | $872K | Hold |
217,485
| – | – | 0.04% | 251 |
|
|
2015
Q3 | $996K | Sell |
217,485
-2,715
| -1% | -$14.2K | 0.07% | 265 |
|
|
2015
Q2 | $1.14M | Hold |
220,200
| – | – | 0.07% | 227 |
|
|
2015
Q1 | $1.38M | Buy |
220,200
+1,000
| +0.5% | +$5.77K | 0.08% | 234 |
|
|
2014
Q4 | $1.38M | Sell |
219,200
-100
| -0% | -$610 | 0.08% | 238 |
|
|
2014
Q3 | $1.33M | Buy |
219,300
+25,100
| +13% | +$171K | 0.08% | 245 |
|
|
2014
Q2 | $1.28M | Buy |
194,200
+15,000
| +8% | +$169K | 0.08% | 238 |
|
|
2014
Q1 | $4.27M | Sell |
179,200
-45,575
| -20% | -$661K | 0.29% | 80 |
|
|
2013
Q4 | $2.4M | Buy |
224,775
+575
| +0.3% | +$6.35K | 0.17% | 140 |
|
|
2013
Q3 | $2.99M | Buy |
224,200
+3,200
| +1% | +$50.6K | 0.21% | 115 |
|
|
2013
Q2 | $2.9M | Buy |
+221,000
| New | +$2.98M | 0.22% | 108 |
|
Other funds holding ECYT
Curi RMB Capital's ECYT Position: Q4 2018 in Review
Curi RMB Capital sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 249,885 shares — an estimated $4.44M sold.
Curi RMB Capital first reported a position in ECYT in Q2 2013 and held it in 22 quarters. The position peaked at $4.44M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.
- Curi RMB Capital reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
- Curi RMB Capital sold 249,885 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $4.44M.
- Curi RMB Capital first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 22 quarters.
- Curi RMB Capital's Endocyte, Inc. Common Stock position peaked at $4.44M in Q3 2018.
- 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.
Based on Curi RMB Capital's 13F filing for Q4 2018, filed 13 Feb 2019.